BioSpace News Archive

Certilytics to participate in upcoming AHIP conference

Certilytics, Inc. today announced it will showcase its healthcare predictive analytics solutions at this year’s AHIP Institute & Expo Online.

June 16, 2021
·
2 min read
Pharm Country

Novo Nordisk to present research across diabetes and obesity portfolio at the 81st Annual American Diabetes Association Scientific Sessions

Novo Nordisk announced that new data from more than 30 abstracts will be presented from the company’s approved and investigational medicines highlighting its broad diabetes and obesity portfolio at the upcoming 81st Annual Scientific Sessions of the American Diabetes Association.

June 16, 2021
·
6 min read
Biotech Bay

Neurona Therapeutics Presents Clinical Development Plan for Lead Cell Therapy Program at the 16th Conference on Antiepileptic Drug and Device Trials (AEDD TRIALS XVI)

Neurona today announced the presentation of clinical trial plans and supporting preclinical data for its lead inhibitory neuron cell therapy candidate, NRTX-1001.

June 16, 2021
·
4 min read
PharmaTher To Present At The H.C. Wainwright Psychedelics In Psychiatry And Beyond Virtual Conference

PharmaTher Holdings Ltd. today announced that Fabio Chianelli, Chief Executive Officer, will be presenting at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17, 2021.

June 16, 2021
·
3 min read
BioForest

Impel NeuroPharma to Present at the Raymond James Human Health Innovation Conference

Impel NeuroPharma today announced that the Company will present a corporate overview at the Raymond James Human Health Innovations Conference on Wednesday, June 23, 2021 at 3:20 p.m. ET.

June 16, 2021
·
1 min read
Business

Apexigen and the Nordic Society of Gynaecological Oncology – Clinical Trial Unit Announce Collaborative Phase 2 Study of Sotigalimab (APX005M)

Apexigen, Inc. today announced an agreement to initiate a collaborative Phase 2 clinical study evaluating sotigalimab,

June 16, 2021
·
4 min read
Biotech Bay

89bio to Participate in Upcoming Investor Conferences

89bio, Inc. today announced that Company’s Management will participate in the following upcoming investor conferences in June: SVB Leerink CybeRx Series: Liver Disease Day Format: One-on-one investor meetings Date: Thursday, June 17, 2021

June 16, 2021
·
1 min read
Drug Development

Aprea Therapeutics Announces Phase 1/2 Trial of Eprenetapopt + Venetoclax + Azacitidine in TP53 Mutant AML Meets Complete Remission Primary Efficacy Endpoint

Aprea Therapeutics, Inc. today announced that the Phase 1/2 trial evaluating the frontline treatment of eprenetapopt with venetoclax and azacitidine in patients with TP53 mutant AML has met the pre-specified primary efficacy endpoint of complete remission rate.

June 16, 2021
·
6 min read
Drug Development

KBP Biosciences Announces A Greater Than 10 mm Hg Systolic Blood Pressure Reduction in The BLOCK-CKD Phase 2b Study of KBP-5074 in Advanced Chronic Kidney Disease Patients with Uncontrolled Hypertension as Published in Hypertension

KBP Biosciences today announced publication of the results of the BLOCK-CKD (Blood Pressure in Chronic Kidney Disease) phase 2b study of KBP-5074.

June 16, 2021
·
6 min read
Enlivex Annouces Participation in A.G.P.’s Upcoming 2021 Virtual Summer Healthcare Symposium

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that members of the Company’s management team will participate in A.G.P.’s Virtual Summer Healthcare Symposium

June 16, 2021
·
3 min read